INDIANAPOLIS (Reuters) – Eli Lilly is in advanced talks to buy Ventyx Biosciences for more than $1 billion, the Wall Street Journal reported on Tuesday, citing people familiar with the matter. Shares ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results